CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics
Open Access
- 27 February 2023
- journal article
- review article
- Published by Springer Nature in Animal Diseases
- Vol. 3 (1) , 1-11
Abstract
Inappropriate use of antibiotics is globally creating public health hazards associated with antibiotic resistance. Bacteria often acquire antibiotic resistance by altering their genes through mutation or acquisition of plasmid-encoding resistance genes. To treat drug-resistant strains of bacteria, the recently developed CRISPR-Cas9 system might be an alternative molecular tool to conventional antibiotics. It disables antibiotic-resistance genes (plasmids) or deactivates bacterial virulence factors and sensitizes drug-resistant bacteria through site-specific cleavage of crucial domains of their genome. This molecular tool uses phages as vehicles for CRISPR-cas9 delivery into bacteria. Since phages are species-specific and natural predators of bacteria, they are capable of easily injecting their DNA to target bacteria. The CRISPR system is packaged into phagemid vectors, in such a way that the bacteria containing the antibiotic-resistance plasmid sequence or that containing specific DNA sequences were made to be targeted. Upon CRISPR delivery, Cas9 is programmed to recognize target sequences through the guide RNA thereby causing double-strand cleavage of targeted bacterial DNA or loss of drug resistance plasmid, which results in cell death. Remarkably, the safety and efficacy of this newly developed biotechnology tool and the biocontrol product need to be further refined for its usage in clinical translation.Keywords
This publication has 71 references indexed in Scilit:
- Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coliNucleic Acids Research, 2012
- Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequenceProceedings of the National Academy of Sciences, 2011
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase IIINature, 2011
- Self-targeting by CRISPR: gene regulation or autoimmunity?Trends in Genetics, 2010
- CRISPR interference: RNA-directed adaptive immunity in bacteria and archaeaNature Reviews Genetics, 2010
- CRISPI: a CRISPR interactive databaseBioinformatics, 2009
- Short motif sequences determine the targets of the prokaryotic CRISPR defence systemMicrobiology, 2009
- Rational de novo gene synthesis by rapid polymerase chain assembly (PCA) and expression of endothelial protein-C and thrombin receptor genesJournal of Biotechnology, 2007
- Refactoring bacteriophage T7Molecular Systems Biology, 2005
- Mechanisms of, and Barriers to, Horizontal Gene Transfer between BacteriaNature Reviews Microbiology, 2005